EYLENBOSCH HILDE 4
4 · ALERE INC. · Filed Jan 28, 2011
Insider Transaction Report
Form 4
ALERE INC.ALR
EYLENBOSCH HILDE
Chief Commercial Officer
Transactions
- Exercise/Conversion
Common Stock
2011-01-26$14.92/sh+4,000$59,680→ 33,303 total(indirect: By Spouse) - Exercise/Conversion
Common Stock
2011-01-26−4,000→ 0 total(indirect: By Spouse)Exercise: $14.92From: 2001-11-21Exp: 2011-02-12→ Common Stock (4,000 underlying)
Holdings
- 4,448
Common Stock
Footnotes (3)
- [F1]This option was acquired through a restructuring transaction undertaken by the Issuer's former parent, Inverness Medical Technology, Inc. in connection with the consummation of the transactions contemplated by the agreement and plan of split-off merger dated as of May 23, 2001 among Johnson & Johnson, Sunrise Acquisition Corp. and Inverness Medical Technology, Inc.
- [F2]This derivative security does not have a price.
- [F3]The reporting person disclaims beneficial ownership of the reported securities.